Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesTestosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09
Khera M – Evidence shows that testosterone, added to estrogen therapy (ET), improves sexual function in women and may improve bone health. However, the absence of an FDA–approved agent, off–label use raises questions about patient selection, dosing, and safety. Approval of testosterone–containing preparations has been deferred pending confirmation of long–term safety assessments (2–5 years). Evidence suggests that testosterone supplementation does not increase the risk of breast cancer; it may have a protective effect on breast tissue. A longer time to disease progression and a higher response rate is observed when androgens are added to anti–estrogen therapy. Long–term androgen administration does not have significant, adverse effects on female breast tissue. Nevertheless, testosterone can still be aromatized to estrogen; patients with a history of estrogen–sensitive breast cancer should be discouraged from treatment. No convincing data suggest that testosterone use increases the risk of cardiovascular events in women. Although oral methyltestosterone has been shown to reduce HDL and raise LDL levels in women, this effect is not seen in association with other forms of testosterone. Finally, no evidence indicates that testosterone supplementation increases the risk of endometrial cancer.
Related Articles
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Relevance Score: 95%
Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 94%
Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
European Journal of Endocrinology, 11/17/09
Relevance Score: 91%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09
Relevance Score: 91%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
NIH, 11/03/09
Relevance Score: 91%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/07/09
Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation
Evidence-Based Medicine, 12/07/09
Today in Family Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
HPV-16/18 vaccine is highly effective in preventing precancerous cervical lesions
The Clinical Advisor, 12/07/09
Health partnerships: perspectives of medical practitioners in general practice, health systems and hospital settings
The Australian Journal of Primary Health, 12/07/09
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
British Medical Journal, 12/07/09
Today in Obstetrics/Gynecology...keeping you current
Receive free subspecialty "5-minute updates" via email
HPV-16/18 vaccine is highly effective in preventing precancerous cervical lesions
The Clinical Advisor, 12/07/09
Pregnancy in peri- and postmenopausal women: challenges in management
Menopause International, 12/07/09
Endometriosis: associations with menopause, hormone replacement therapy and cancer
Menopause International, 12/07/09
Today in Women`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
HPV-16/18 vaccine is highly effective in preventing precancerous cervical lesions
The Clinical Advisor, 12/07/09
Correlates of use of antifracture therapy in older women with low bone mineral density
Journal of General Internal Medicine, 12/07/09
Adjuvant Phytotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-Analysis
Journal of Alternative and Complementary Medicine, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor